...
首页> 外文期刊>BMC Surgery >Tubeless uniportal thoracoscopic wedge resection with modified air leak test and chest tube drainage
【24h】

Tubeless uniportal thoracoscopic wedge resection with modified air leak test and chest tube drainage

机译:无管Uniportal胸镜楔切除改性空气泄漏试验和胸管排水

获取原文
           

摘要

To investigate whether tubeless uniportal thoracoscopic wedge resection with modified air leak test and chest tube drainage has better short-term outcomes than non-intubated approach with chest tube drainage. Data were collected retrospectively from January 2017 and December 2019. Tubeless group included 55 patients with pulmonary nodules underwent tubeless uniportal thoracoscopic wedge resection, 211 patients underwent non-intubated uniportal thoracoscopic wedge resection with chest tube drainage were included in drainage group. Peri-operative outcomes between two groups were compared. After 1:1 matching, 110 patients remained for analysis, baseline demographic and clinical variables were comparable between the two groups. Mean incision size was 3?cm in both group. Mean operative time was 59.3?min in tubeless group and 52.8?min in drainage group. The detectable mean lowest SpO2 and mean peak EtCO2 during operation was acceptable in both groups. Conversion to intubated ventilation or thoracotomy was not required. No patient failed the air leak test and did not undergo a tubeless procedure. Mean postoperative hospital stay was 1.5?days in tubeless group and 2.5?days in drainage group. Residual pneumothorax or subcutaneous emphysema was not frequent and mild in tubeless group. Side effects were rare and mild, including cough and hemoptysis. No re-intervention or readmission occurred. The postoperative VAS score was significantly lower in tubeless group. Tubeless uniportal thoracoscopic wedge resection with modified air leak test and chest tube drainage is feasible and safe for selected patients with peripheral pulmonary nodules, it might reduce post-operation pain and lead to faster recovery.
机译:为了探讨无管Uniportal胸腔镜楔切除改性的空气泄漏试验和胸管排水是否具有比具有胸管排水的非加管方法更好的短期结果。从2017年1月和2019年12月回顾性地收集了数据。无内置的组55例肺结结患者接受了无管Uniportal胸镜楔切除的患者,211名患者接受了胸管引流的非加管单胸镜楔切除术中的患者。比较了两组之间的围手术结果。 1:1匹配后,110名患者留下分析,两组之间的基线人口统计和临床变量相当。两组的平均切口尺寸为3?cm。在无管组中的平均手术时间为59.3次,排水组中的52.8分钟。在操作期间,可检测的平均最低SPO2和平均峰ETCO2在两个组中可接受。不需要转化为插管的通风或胸廓切开术。没有患者失败的空气泄漏测试,并且没有经过无管制程序。意味着术后住院住宿1.5个?无管集团的日子,在排水组中有2.5天。残留的气胸或皮下肺气肿在无管组中没有频繁和轻度。副作用稀有,温和,包括咳嗽和咯血。没有发生重新干预或入院。术后VAS得分在无管组中显着降低。无管Uniportal胸腔镜楔形楔分切除改性的空气泄漏试验和胸管排水是选择的外周肺结核患者的可行和安全,可能会降低操作后疼痛并导致更快的恢复。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号